Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss drug.

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...

GLP-1 agonist users had a 17% lower cancer risk compared to non-users in a large retrospective study. The reductions achieved ...

Tennis legend Serena Williams is sharing her journey with weight loss drugs, saying she's lost 31 pounds in 8 months using GLP-1s.

I never was able to get to the weight I needed to be no matter what I did, no matter how much I trained,” the tennis legend ...

SERENA Williams has revealed she used fat jabs to shed pounds after giving birth to her two daughters. The tennis star has ...

Serena Williams has just publicly admitted to using GLP-1 medication for weight loss. The 23-time Grand Slam champion says ...

Mounjaro (tirzepatide) : Lilly's dual GIP/GLP-1 agonist has delivered best-in-class weight loss and glycemic control in T2D and, under its obesity brand Zepbound , has outperformed semaglutide in head ...

The 43-year-old tennis legend has opened up on her drastic weight loss journey, revealing that she has shed 31 pounds over the course of the past year. But admitted that she's had a helping hand.

Serena Williams is getting real about her weight-loss journey. Since April, the retired tennis legend has been on a GLP-1 ...

Serena Williams opens up about hitting a weight loss plateau and why she turned to Zepbound to achieve her fitness goals.